Profile - To The Moon

johnson69

Posts · 6Posts · 6
Following · 0Following · 0
Followers · 0Followers · 0

- johnson69johnson69
  ·2021-05-31
  always hold and never sell even whenyou are losing
  2 Deeply Discounted Dividend Stocks to Buy and Hold Right Now
  These pharmaceutical companies might make great long-term additions to your portfolio.
  2 Deeply Discounted Dividend Stocks to Buy and Hold Right Now
  336 Comment
  1
  Share
  Report
- johnson69johnson69
  ·2021-05-28
  vegan vegan
  Why Beyond Meat Stock Jumped Thursday
  An influential stock picker says the company should be the next meme stock.
  Why Beyond Meat Stock Jumped Thursday
  189 Comment
  Like
  Share
  Report
- johnson69johnson69
  ·2021-05-28
  vegan for the win
  Sorry, this post has been deleted
  186 Comment
  Like
  Share
  Report
- johnson69johnson69
  ·2021-04-20
  very detailed report
  7 Earnings Reports to Watch This Week
  Here are the big earnings reports for investors to monitor.Once again, earnings season is here. And, once again, major market indices are at all-time highs — making these earnings reports to watch even more enticing.It’s deja vu all over again, as the saying goes. For most of the past 11 years, stocks have kept rising, and earnings reports have been good enough to keep the rallies intact.At the moment, this market doesn’t look much different. Big banks kicked off earnings season last week with a
  7 Earnings Reports to Watch This Week
  275 Comment
  Like
  Share
  Report
- johnson69johnson69
  ·2021-04-20
  apple is great :)
  Sorry, this post has been deleted
  262 Comment
  4
  Share
  Report
- johnson69johnson69
  ·2021-04-20
  apple is great
  Should You Buy Apple Stock Before Next Apple Event?
  On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Ap
  Should You Buy Apple Stock Before Next Apple Event?
  109 Comment
  Like
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3581676194356767","uuid":"3581676194356767","gmtCreate":1618582170228,"gmtModify":1618884949041,"name":"johnson69","pinyin":"johnson69","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/427e67743c2dda94609a151f247459a0","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":111,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.39%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.07","exceedPercentage":"80.19%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":110954159,"gmtCreate":1622423192671,"gmtModify":1704184081183,"author":{"id":"3581676194356767","authorId":"3581676194356767","name":"johnson69","avatar":"https://static.tigerbbs.com/427e67743c2dda94609a151f247459a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581676194356767","authorIdStr":"3581676194356767"},"themes":[],"htmlText":"always hold and never sell even whenyou are losing&nbsp;","listText":"always hold and never sell even whenyou are losing&nbsp;","text":"always hold and never sell even whenyou are losing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/110954159","repostId":"2139480953","repostType":4,"repost":{"id":"2139480953","pubTimestamp":1622421908,"share":"https://ttm.financial/m/news/2139480953?lang=&edition=fundamental","pubTime":"2021-05-31 08:45","market":"us","language":"en","title":"2 Deeply Discounted Dividend Stocks to Buy and Hold Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2139480953","media":"Motley Fool","summary":"These pharmaceutical companies might make great long-term additions to your portfolio.","content":"<p>Finding bargains can be a tough challenge even in a market that's going down. But there are always discounts to be had, and two great blue-chip companies -- <b>AstraZeneca </b>(NASDAQ:AZN) and <b>GlaxoSmithKline </b>(NYSE:GSK) -- are currently selling for bargain prices. Both offer solid dividends in the mix, meaning that a buy-and-hold strategy with these stocks in your portfolio could prove quite fruitful over the long run.</p>\n<p>Here's why you may want to take a look at these two companies.</p>\n<p><img src=\"https://static.tigerbbs.com/6241bdb32e48148eeb1bcc68b793ec25\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\">Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h2>1. AstraZeneca</h2>\n<p>Still down from its all-time highs of $61 set back in July 2020, AstraZeneca is currently in a great spot to possibly break through that record and head higher. Trading at a forward price-to-earnings ratio of just 15.23, the stock looks cheap compared with a year ago, when it traded at its average market valuation with a forward P/E of 20 -- a level it's maintained for the past five years, indicating that today's valuation is a discount.</p>\n<p>Its current discount can be attributed to a tremendous growth in earnings to which the stock price has yet to catch up, highlighting the immense potential AstraZeneca has to rise. Its 2018 earnings per share were $1.70, 2019's were $1.03, and 2020's were $2.44 -- a remarkable jump.</p>\n<p>AstraZeneca's new drugs are <a href=\"https://laohu8.com/S/AONE\">one</a> reason for optimism about its growth. One in particular that shows incredible promise is Fasenra, for severe asthma. Fasenra's sales potential looks especially impressive given the market in which it operates. The global asthma market in 2020 came in at $20.6 billion, which could provide a lot of potential for Fasenra -- already a near-blockbuster, with nearly $1 billion in 2020 sales -- to grow and take market share away from <b>GlaxoSmithKline</b>'s Nucala and <b><a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>'</b>s Dupixient. Doctors already seem to prefer Fasenra thanks to its more precise dosing, and Fasenra could end up bringing AstraZeneca several billion dollars annually.</p>\n<p>Eventually, AstraZeneca's stock price will catch up with its revenue growth. Taking analysts' EPS estimates of $3.77 for the year and figuring on a P/E of 21, we are looking at a $79 share price -- a 38% return on this discounted stock should it return to the valuation which the market has historically applied.</p>\n<p>AstraZeneca also pays a dividend, yielding 2.44%, almost double the <b>SPDR S&amp;P 500</b> ETF's 1.3%. With a reliable dividend history going back to 1999 and potential for lots of upside, AstraZeneca is worth considering as a set-and-forget stock.</p>\n<h2>2. GlaxoSmithKline</h2>\n<p>Founded in 1715 as a small apothecary shop, GlaxoSmithKline has spent more than 300 years growing into the multinational pharmaceutical company we know today. The business behind such brand names as Aquafresh, Nicorette, Sensodyne, and Tums, GlaxoSmithKline is familiar to consumers worldwide.</p>\n<p>The company today sits off recent highs of more than $45 a share set before March 2020. It currently trades at about $39, and looks inexpensive at that valuation, with a forward P/E of 13.98. Its five-year average forward P/E has been 14.59, so buying today could be getting the stock cheap. If it rises to back to its highs, investors would reap a 15% return; even if it only reverts to its normal market valuation, the return would be 9.5%.</p>\n<p>Management has discussed potentially cutting the dividend as the company spins off its consumer health segment in 2022. That division brought in 10 billion pounds in 2020, or almost 30% of total revenue (34 billion pounds). The company is making this move to help transform itself into a research and development-focused biopharma; the spun-off segment will focus on consumer health. Dividend investors value safe payouts, and a dividend cut makes sense for a business that's spinning off a segment that's been adding to revenue. Without a cut, the payout ratio after the spinoff would be very high, and the company might not be able to meet its obligations to pay shareholders, making the dividend unsustainable.</p>\n<p>Thus, this move should bring safety to the dividend and to the financial health of the company. GlaxoSmithKline can use that excess cash to reinvest into other parts of the business to drive future revenue growth. One such business is its vaccine segment; the company is currently co-developing a COVID-19 vaccine with pharmaceutical company Sanofi. So far, the partners have garnered a $2.1 billion contract with the U.S. gvernment to develop and deliver 100 million doses of their vaccine, and deals with the European Union and Canada to deliver 300 million and 60 million doses to those areas respectively.</p>\n<p>While the financials of the latter two deals have yet to be been disclosed, the terms are likely similar to those reached with the U.S. Such deals have the potential to bring billions in revenue, not just in the near term but for the future as the world continues to fight against COVID-19.</p>\n<p>When looking for stocks to buy and hold, safety and stability must be taken into account. Still off its highs, GlaxoSmithKline has a lot more room to grow in share price, and given the dividend cut, its payout should be much more secure as part of a long-term strategy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Deeply Discounted Dividend Stocks to Buy and Hold Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Deeply Discounted Dividend Stocks to Buy and Hold Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-31 08:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/30/deeply-discounted-dividend-stocks-to-buy-and-hold/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Finding bargains can be a tough challenge even in a market that's going down. But there are always discounts to be had, and two great blue-chip companies -- AstraZeneca (NASDAQ:AZN) and ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/30/deeply-discounted-dividend-stocks-to-buy-and-hold/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","GSK":"葛兰素史克"},"source_url":"https://www.fool.com/investing/2021/05/30/deeply-discounted-dividend-stocks-to-buy-and-hold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2139480953","content_text":"Finding bargains can be a tough challenge even in a market that's going down. But there are always discounts to be had, and two great blue-chip companies -- AstraZeneca (NASDAQ:AZN) and GlaxoSmithKline (NYSE:GSK) -- are currently selling for bargain prices. Both offer solid dividends in the mix, meaning that a buy-and-hold strategy with these stocks in your portfolio could prove quite fruitful over the long run.\nHere's why you may want to take a look at these two companies.\nImage source: Getty Images.\n1. AstraZeneca\nStill down from its all-time highs of $61 set back in July 2020, AstraZeneca is currently in a great spot to possibly break through that record and head higher. Trading at a forward price-to-earnings ratio of just 15.23, the stock looks cheap compared with a year ago, when it traded at its average market valuation with a forward P/E of 20 -- a level it's maintained for the past five years, indicating that today's valuation is a discount.\nIts current discount can be attributed to a tremendous growth in earnings to which the stock price has yet to catch up, highlighting the immense potential AstraZeneca has to rise. Its 2018 earnings per share were $1.70, 2019's were $1.03, and 2020's were $2.44 -- a remarkable jump.\nAstraZeneca's new drugs are one reason for optimism about its growth. One in particular that shows incredible promise is Fasenra, for severe asthma. Fasenra's sales potential looks especially impressive given the market in which it operates. The global asthma market in 2020 came in at $20.6 billion, which could provide a lot of potential for Fasenra -- already a near-blockbuster, with nearly $1 billion in 2020 sales -- to grow and take market share away from GlaxoSmithKline's Nucala and Sanofi's Dupixient. Doctors already seem to prefer Fasenra thanks to its more precise dosing, and Fasenra could end up bringing AstraZeneca several billion dollars annually.\nEventually, AstraZeneca's stock price will catch up with its revenue growth. Taking analysts' EPS estimates of $3.77 for the year and figuring on a P/E of 21, we are looking at a $79 share price -- a 38% return on this discounted stock should it return to the valuation which the market has historically applied.\nAstraZeneca also pays a dividend, yielding 2.44%, almost double the SPDR S&P 500 ETF's 1.3%. With a reliable dividend history going back to 1999 and potential for lots of upside, AstraZeneca is worth considering as a set-and-forget stock.\n2. GlaxoSmithKline\nFounded in 1715 as a small apothecary shop, GlaxoSmithKline has spent more than 300 years growing into the multinational pharmaceutical company we know today. The business behind such brand names as Aquafresh, Nicorette, Sensodyne, and Tums, GlaxoSmithKline is familiar to consumers worldwide.\nThe company today sits off recent highs of more than $45 a share set before March 2020. It currently trades at about $39, and looks inexpensive at that valuation, with a forward P/E of 13.98. Its five-year average forward P/E has been 14.59, so buying today could be getting the stock cheap. If it rises to back to its highs, investors would reap a 15% return; even if it only reverts to its normal market valuation, the return would be 9.5%.\nManagement has discussed potentially cutting the dividend as the company spins off its consumer health segment in 2022. That division brought in 10 billion pounds in 2020, or almost 30% of total revenue (34 billion pounds). The company is making this move to help transform itself into a research and development-focused biopharma; the spun-off segment will focus on consumer health. Dividend investors value safe payouts, and a dividend cut makes sense for a business that's spinning off a segment that's been adding to revenue. Without a cut, the payout ratio after the spinoff would be very high, and the company might not be able to meet its obligations to pay shareholders, making the dividend unsustainable.\nThus, this move should bring safety to the dividend and to the financial health of the company. GlaxoSmithKline can use that excess cash to reinvest into other parts of the business to drive future revenue growth. One such business is its vaccine segment; the company is currently co-developing a COVID-19 vaccine with pharmaceutical company Sanofi. So far, the partners have garnered a $2.1 billion contract with the U.S. gvernment to develop and deliver 100 million doses of their vaccine, and deals with the European Union and Canada to deliver 300 million and 60 million doses to those areas respectively.\nWhile the financials of the latter two deals have yet to be been disclosed, the terms are likely similar to those reached with the U.S. Such deals have the potential to bring billions in revenue, not just in the near term but for the future as the world continues to fight against COVID-19.\nWhen looking for stocks to buy and hold, safety and stability must be taken into account. Still off its highs, GlaxoSmithKline has a lot more room to grow in share price, and given the dividend cut, its payout should be much more secure as part of a long-term strategy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":336,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135522298,"gmtCreate":1622171228114,"gmtModify":1704180822798,"author":{"id":"3581676194356767","authorId":"3581676194356767","name":"johnson69","avatar":"https://static.tigerbbs.com/427e67743c2dda94609a151f247459a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581676194356767","authorIdStr":"3581676194356767"},"themes":[],"htmlText":"vegan vegan","listText":"vegan vegan","text":"vegan vegan","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/135522298","repostId":"2138173174","repostType":4,"repost":{"id":"2138173174","pubTimestamp":1622165400,"share":"https://ttm.financial/m/news/2138173174?lang=&edition=fundamental","pubTime":"2021-05-28 09:30","market":"us","language":"en","title":"Why Beyond Meat Stock Jumped Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2138173174","media":"Motley Fool","summary":"An influential stock picker says the company should be the next meme stock.","content":"<h3>What happened</h3>\n<p>Shares of plant-based meat producer <b>Beyond Meat</b> (NASDAQ:BYND) jumped Thursday morning for what some might consider a surprising reason. As of 10:15 a.m. EDT Thursday, shares were up more than 13%.</p>\n<h3>So what</h3>\n<p>The surge is likely the result of some commentary from CNBC's Jim Cramer. On his <i>Mad Money</i> show Wednesday night, Cramer said the WallStreetBets crowd should make Beyond Meat the next meme stock to drive a short squeeze. The comment came after recent gains in stocks including <b>AMC Entertainment Holdings</b> (NYSE:AMC) and <b>GameStop</b> (NYSE:GME) brought back visions of exponential gains in January as Reddit forum users banded together to push those shares higher.</p>\n<p><img src=\"https://static.tigerbbs.com/f5b7919f441ad56e45bfbc28db2ad755\" tg-width=\"700\" tg-height=\"399\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Now what</h3>\n<p>Cramer specifically noted that Beyond Meat has about 25% of its shares held short, setting up a scenario that could result in sharp gains from a short squeeze. High short positions were the trigger that drove users of Reddit's WallStreetBets forum in January to force short covering in GameStop. The result was an exponential rise in the share price, surpassing what most anyone believed had any fundamental business explanation.</p>\n<p>Cramer was making two points with his suggestion yesterday. First, he is a believer in the underlying business and thinks Beyond Meat has a long runway for growth. But he was also pointing out that the retail-trading crowd that spurred the frenzy earlier in the year continues to have power in numbers, and could create a show of force in the stock market again. Long-term investors should focus on the former. Those who want to try to time gains from a short squeeze should only play that game with gambling money.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Beyond Meat Stock Jumped Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Beyond Meat Stock Jumped Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-28 09:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/27/why-beyond-meat-stock-jumped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of plant-based meat producer Beyond Meat (NASDAQ:BYND) jumped Thursday morning for what some might consider a surprising reason. As of 10:15 a.m. EDT Thursday, shares were up more...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/27/why-beyond-meat-stock-jumped-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BYND":"Beyond Meat, Inc."},"source_url":"https://www.fool.com/investing/2021/05/27/why-beyond-meat-stock-jumped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138173174","content_text":"What happened\nShares of plant-based meat producer Beyond Meat (NASDAQ:BYND) jumped Thursday morning for what some might consider a surprising reason. As of 10:15 a.m. EDT Thursday, shares were up more than 13%.\nSo what\nThe surge is likely the result of some commentary from CNBC's Jim Cramer. On his Mad Money show Wednesday night, Cramer said the WallStreetBets crowd should make Beyond Meat the next meme stock to drive a short squeeze. The comment came after recent gains in stocks including AMC Entertainment Holdings (NYSE:AMC) and GameStop (NYSE:GME) brought back visions of exponential gains in January as Reddit forum users banded together to push those shares higher.\n\nImage source: Getty Images.\nNow what\nCramer specifically noted that Beyond Meat has about 25% of its shares held short, setting up a scenario that could result in sharp gains from a short squeeze. High short positions were the trigger that drove users of Reddit's WallStreetBets forum in January to force short covering in GameStop. The result was an exponential rise in the share price, surpassing what most anyone believed had any fundamental business explanation.\nCramer was making two points with his suggestion yesterday. First, he is a believer in the underlying business and thinks Beyond Meat has a long runway for growth. But he was also pointing out that the retail-trading crowd that spurred the frenzy earlier in the year continues to have power in numbers, and could create a show of force in the stock market again. Long-term investors should focus on the former. Those who want to try to time gains from a short squeeze should only play that game with gambling money.","news_type":1},"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135526331,"gmtCreate":1622171174623,"gmtModify":1704180821148,"author":{"id":"3581676194356767","authorId":"3581676194356767","name":"johnson69","avatar":"https://static.tigerbbs.com/427e67743c2dda94609a151f247459a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581676194356767","authorIdStr":"3581676194356767"},"themes":[],"htmlText":"vegan for the win","listText":"vegan for the win","text":"vegan for the win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/135526331","repostId":"2138173174","repostType":4,"isVote":1,"tweetType":1,"viewCount":186,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373539435,"gmtCreate":1618871140227,"gmtModify":1704716012724,"author":{"id":"3581676194356767","authorId":"3581676194356767","name":"johnson69","avatar":"https://static.tigerbbs.com/427e67743c2dda94609a151f247459a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581676194356767","authorIdStr":"3581676194356767"},"themes":[],"htmlText":"very detailed report","listText":"very detailed report","text":"very detailed report","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/373539435","repostId":"1114523776","repostType":4,"repost":{"id":"1114523776","pubTimestamp":1618801660,"share":"https://ttm.financial/m/news/1114523776?lang=&edition=fundamental","pubTime":"2021-04-19 11:07","market":"us","language":"en","title":"7 Earnings Reports to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1114523776","media":"InvestorPlace","summary":"Here are the big earnings reports for investors to monitor.Once again, earnings season is here. And, once again, major market indices are at all-time highs — making these earnings reports to watch even more enticing.It’s deja vu all over again, as the saying goes. For most of the past 11 years, stocks have kept rising, and earnings reports have been good enough to keep the rallies intact.At the moment, this market doesn’t look much different. Big banks kicked off earnings season last week with a","content":"<blockquote><b>Here are the big earnings reports for investors to monitor.</b></blockquote><p>Once again, earnings season is here. And, once again, major market indices are at all-time highs — making these earnings reports to watch even more enticing.</p><p>It’s deja vu all over again, as the saying goes. For most of the past 11 years, stocks have kept rising, and earnings reports have been good enough to keep the rallies intact.</p><p>At the moment, this market doesn’t look much different. Big banks kicked off earnings season last week with a slew of strong reports. The economy is in better shape than might be expected at this point. Despite selloffs in a few ‘hot’ sectors, and another brief bout of interest rate worries, investor sentiment too remains positive.</p><p>Basically, corporate earnings just need to keep the party going. That’s particularly true over the next few weeks, as the earnings calendar features some of the world’s largest companies across the market’s biggest and most important sectors. They’re the kind of companies whose reports can move entire sectors — and, in a few cases, perhaps the entire market.</p><p>For the next few weeks, earnings reports will take center stage. For this week, these are the seven earnings reports to watch:</p><ul><li><b>Coca-Cola</b>(NYSE:<b><u>KO</u></b>)</li><li><b>IBM</b>(NYSE:<b><u>IBM</u></b>)</li><li><b>Johnson &amp; Johnson</b>(NYSE:<b><u>JNJ</u></b>)</li><li><b>Procter &amp; Gamble</b>(NYSE:<b><u>PG</u></b>)</li><li><b>Netflix</b>(NASDAQ:<b><u>NFLX</u></b>)</li><li><b>AT&amp;T</b>(NYSE:<b><u>T</u></b>)</li><li><b>Intel</b>(NASDAQ:<b><u>INTC</u></b>)</li></ul><p>Now, let’s dive in and take a closer look at each one.</p><p><b>Earnings Reports to Watch: Coca-Cola (KO)</b></p><p><b>Earnings Report Date</b>: Monday, April 19, before market open</p><p>In an uncertain environment, the broad reach of the world’s largest beverage company makes earnings this week important for almost every investor.</p><p>After all, both of the company’s channels are in uncharted waters. In supermarkets, the question is how food and beverage companies will fare against the enormously difficult comparisons of last year’s first quarter, and March specifically. In takeaway, the return to normalcy no doubt is providing some help — but how much?</p><p>Coke earnings should give some color on both sides of the business — and not just for Coke, but its rivals and peers.</p><p>It’s an important release for Coca-Cola itself. KO stock still hasn’t clawed back all of the losses it suffered in February and March of last year. Shares in fact are more than 10% off their all-time highs.</p><p>That creates an obvious opportunity. A Coca-Cola that is back to normal should lead to a KO stock that too is back to normal. Add in a dividend yield over 3% and investors would see double-digit returns. If Coca-Cola convinces investors that normalcy is just around the corner, those returns may arrive relatively quickly.</p><p><b>IBM (IBM)</b></p><p><b>Earnings Report Date</b>: Monday, April 19, after market close</p><p>Every earnings report is key for IBM. The company is in the midst of a multi-year turnaround which still hasn’t gained real traction.</p><p>Shares still are down more than one-third from 2013 highs in a market where tech stocks have soared. IBM saw revenue decline for22-consecutive quartersbefore breaking the streak in the fourth quarter of 2017. The top lineturned south againbefore the acquisition of<b>Red Hat</b>added inorganic growth.</p><p>But now Red Hat should be integrated, and bulls see IBM’s cloud business as a potential growth driver. That optimism was enough to push IBM stock to a 52-week high late last month before a recent, modest pullback.</p><p>After the really, expectations certainly aren’t sky-high, but the market no doubt is expecting progress. Anything less, and the “same old IBM” narrative likely follows earnings this week. It’s hard to see how that narrative leads to another round of new highs.</p><p><b>Earnings Reports to Watch: Johnson &amp; Johnson (JNJ)</b></p><p><b>Earnings Report Date</b>: Tuesday, April 20, before market open</p><p>The market quickly looked pastthe pause in J&amp;J’s Covid-19 vaccineannounced last week. After opening down 3% on Tuesday morning, JNJ stock now is essentially flat for the week.</p><p>There no doubt will be some analyst questions on the first quarter conference call about the vaccine. But investor attention likely will focus on the rest of the business, given J&amp;Jisn’t making much profiton the vaccine.</p><p>And there are real questions to be answered. J&amp;J’s medical device business struggled in 2020, with revenue down more than 10% amid lower elective surgeries. A rebound there could signal a bottom and lift other stocks with similar exposure. The same is true for the skin health and beauty businesses within J&amp;J’s consumer products segment.</p><p>And of course the pharmaceutical remains J&amp;J’s largest, at about 60% of revenue. Products like Stelara and Remicade are far more important to the company’s bottom line than is the Covid-19 vaccine.</p><p>With normalcy returning here in 2021, J&amp;J does seem set up for a good quarter. And that could boost optimism toward a long-term casethat remains attractive.</p><p><b>Procter &amp; Gamble (PG)</b></p><p><b>Earnings Report Date</b>: Tuesday, April 20, before market open</p><p>CPG (consumer packaged goods) companies like P&amp;G were early and obvious winners from the pandemic. A surge in supermarket revenue and consumer stockpiling led to unusually high growth.</p><p>But normalcy is returning — which isn’t necessarily great news for P&amp;G and its industry. Toilet paper sales, for instance,have plunged this yearas many consumers still are working through purchases made last year.</p><p>Those trends set up a big fiscal third quarter release for P&amp;G on Tuesday morning. PG stock has rallied in recent weeks after fading to an eight-month low in early March. A 23x forward price-to-earnings multiple is well above recent levels. And Q3 is the first of several quarters in which the company will face difficult, pandemic-driven, year-prior comparisons.</p><p>Particularly with PG up about 12% in six weeks, Q3 results need to be strong ahead of more difficult compares in fiscal Q4 and fiscal Q1. If they’re not, PG stock could stumble after the release — and bring other CPG stocks with it.</p><p><b>Earnings Reports to Watch: Netflix (NFLX)</b></p><p><b>Earnings Report Date</b>: Tuesday, April 20, after market close</p><p>Netflix too seems like an obvious pandemic winner. Early on, NFLX stock was treated as such, as it rallied quickly off March 2020 lows and touched an all-time high in early July.</p><p>Since then, however, NFLX has been stuck. One obvious reason why is that investor attention has turned to other streaming plays such as<b>Roku</b>(NASDAQ:<b><u>ROKU</u></b>) and direct Netflix competitors<b>Disney</b>(NYSE:<b><u>DIS</u></b>) and<b>ViacomCBS</b>(NASDAQ:<b><u>VIAC</u></b>,NASDAQ:<b><u>VIACA</u></b>).</p><p>But earnings haven’t necessarily helped, either. NFLX stock did jump after January’s Q4 report despite a bottom-line miss, but the gains receded in a matter of weeks. Subscriber growthslowed in Q3, which the company attributed to the spike in sign-ups amid the pandemic.</p><p>With normalcy returning, earnings this week can set the 2021 narrative. A blowout quarter in the face of so much new competition establishes Netflix as the king of streaming, with other services simply fighting for second place. Any weakness, particularly in the subscriber count, might suggest that those new platforms are pulling Netflix subscribers away.</p><p>With the forward earnings multiple down to a more reasonable 43x, NFLX stock is cheap enough to break out if its dominance appears assured. And with incremental margins from additional subscribers driving the expected profit growth, it’s expensive enough to plunge if top-line momentum slows. This looks like a big quarter for NFLX stock — and big enough to move other streaming names as well.</p><p><b>AT&amp;T (T)</b></p><p><b>Earnings Report Date</b>: Thursday, April 22, before market open</p><p>One of those new Netflix competitors, of course, is AT&amp;T. The telecommunications giant launched its HBO Max streaming service in May. Despiteclearing 60 million worldwide subscribersby the end of last year, HBO Max hasn’t done much for T stock.</p><p>Of course, nothing has done much for the stock, which actually is down 2% over the past decade. Investors have received a generally healthy dividend, which now yields 7%. But in terms of share price appreciation, AT&amp;T stock has been the definition of ‘dead money’.</p><p>Something needs to change. It’s hard to see what that will be. HBO Max’s growth has been impressive, but the streaming business is cannibalizing revenue from DIRECTV as well as WarnerMedia’s TNT and TBS cable channels. In wireless, AT&amp;T continues to lose share to<b>Verizon Communications</b>(NYSE:<b><u>VZ</u></b>), which reports on Wednesday morning, and a now-larger<b>T-Mobile</b>(NASDAQ:<b><u>TMUS</u></b>).</p><p>Simply put, beyond the dividend yield AT&amp;T hasn’t given investors a good reason to own T stock. It needs to start doing so, and Thursday morning would be a fine time to start. AT&amp;T needs to print sustainable growth either in wireless or in WarnerMedia as a whole. Of course, as the last few years show, that’s easier said than done.</p><p><b>Earnings Reports to Watch: Intel (INTC)</b></p><p><b>Earnings Report Date</b>: Thursday, April 22, after market close</p><p>Earnings this week look absolutely crucial for Intel. INTC plunged after back-to-back earnings reports last year amidyet another stumblein its move to the 7nm node. News in December that<b>Apple</b>(NASDAQ:<b><u>AAPL</u></b>) and<b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) weredeveloping their own chipsended a relief rally and sent the stock back to the lows.</p><p>Yet earlier this month INTC threatened its highest level since a brief 2000 peak amid the dot-com bubble. A better-than-expected Q4 release in January certainly helped. But the chip shortage has proved a catalyst as well. In this environment, Intel’s owned manufacturing capacity gives it an edge over ‘fabless’ rivals<b>Advanced Micro Devices</b>(NASDAQ:<b><u>AMD</u></b>) and<b>Nvidia</b>(NASDAQ:<b><u>NVDA</u></b>).</p><p>In other words, Intel has gotten a reprieve. It’s an advantage the company absolutely must take advantage of. With INTC still trading at 14x forward earnings, the stock is cheap enough that the rally can continue if Intel doesn’t give investors a reason to sell.</p><p>That might seem like a low bar to clear — but Intel’s recent history suggests otherwise.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Earnings Reports to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Earnings Reports to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-19 11:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/earnings-reports-to-watch-next-week/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here are the big earnings reports for investors to monitor.Once again, earnings season is here. And, once again, major market indices are at all-time highs — making these earnings reports to watch ...</p>\n\n<a href=\"https://investorplace.com/earnings-reports-to-watch-next-week/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PG":"宝洁","IBM":"IBM","T":"美国电话电报","JNJ":"强生","KO":"可口可乐","NFLX":"奈飞","INTC":"英特尔"},"source_url":"https://investorplace.com/earnings-reports-to-watch-next-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114523776","content_text":"Here are the big earnings reports for investors to monitor.Once again, earnings season is here. And, once again, major market indices are at all-time highs — making these earnings reports to watch even more enticing.It’s deja vu all over again, as the saying goes. For most of the past 11 years, stocks have kept rising, and earnings reports have been good enough to keep the rallies intact.At the moment, this market doesn’t look much different. Big banks kicked off earnings season last week with a slew of strong reports. The economy is in better shape than might be expected at this point. Despite selloffs in a few ‘hot’ sectors, and another brief bout of interest rate worries, investor sentiment too remains positive.Basically, corporate earnings just need to keep the party going. That’s particularly true over the next few weeks, as the earnings calendar features some of the world’s largest companies across the market’s biggest and most important sectors. They’re the kind of companies whose reports can move entire sectors — and, in a few cases, perhaps the entire market.For the next few weeks, earnings reports will take center stage. For this week, these are the seven earnings reports to watch:Coca-Cola(NYSE:KO)IBM(NYSE:IBM)Johnson & Johnson(NYSE:JNJ)Procter & Gamble(NYSE:PG)Netflix(NASDAQ:NFLX)AT&T(NYSE:T)Intel(NASDAQ:INTC)Now, let’s dive in and take a closer look at each one.Earnings Reports to Watch: Coca-Cola (KO)Earnings Report Date: Monday, April 19, before market openIn an uncertain environment, the broad reach of the world’s largest beverage company makes earnings this week important for almost every investor.After all, both of the company’s channels are in uncharted waters. In supermarkets, the question is how food and beverage companies will fare against the enormously difficult comparisons of last year’s first quarter, and March specifically. In takeaway, the return to normalcy no doubt is providing some help — but how much?Coke earnings should give some color on both sides of the business — and not just for Coke, but its rivals and peers.It’s an important release for Coca-Cola itself. KO stock still hasn’t clawed back all of the losses it suffered in February and March of last year. Shares in fact are more than 10% off their all-time highs.That creates an obvious opportunity. A Coca-Cola that is back to normal should lead to a KO stock that too is back to normal. Add in a dividend yield over 3% and investors would see double-digit returns. If Coca-Cola convinces investors that normalcy is just around the corner, those returns may arrive relatively quickly.IBM (IBM)Earnings Report Date: Monday, April 19, after market closeEvery earnings report is key for IBM. The company is in the midst of a multi-year turnaround which still hasn’t gained real traction.Shares still are down more than one-third from 2013 highs in a market where tech stocks have soared. IBM saw revenue decline for22-consecutive quartersbefore breaking the streak in the fourth quarter of 2017. The top lineturned south againbefore the acquisition ofRed Hatadded inorganic growth.But now Red Hat should be integrated, and bulls see IBM’s cloud business as a potential growth driver. That optimism was enough to push IBM stock to a 52-week high late last month before a recent, modest pullback.After the really, expectations certainly aren’t sky-high, but the market no doubt is expecting progress. Anything less, and the “same old IBM” narrative likely follows earnings this week. It’s hard to see how that narrative leads to another round of new highs.Earnings Reports to Watch: Johnson & Johnson (JNJ)Earnings Report Date: Tuesday, April 20, before market openThe market quickly looked pastthe pause in J&J’s Covid-19 vaccineannounced last week. After opening down 3% on Tuesday morning, JNJ stock now is essentially flat for the week.There no doubt will be some analyst questions on the first quarter conference call about the vaccine. But investor attention likely will focus on the rest of the business, given J&Jisn’t making much profiton the vaccine.And there are real questions to be answered. J&J’s medical device business struggled in 2020, with revenue down more than 10% amid lower elective surgeries. A rebound there could signal a bottom and lift other stocks with similar exposure. The same is true for the skin health and beauty businesses within J&J’s consumer products segment.And of course the pharmaceutical remains J&J’s largest, at about 60% of revenue. Products like Stelara and Remicade are far more important to the company’s bottom line than is the Covid-19 vaccine.With normalcy returning here in 2021, J&J does seem set up for a good quarter. And that could boost optimism toward a long-term casethat remains attractive.Procter & Gamble (PG)Earnings Report Date: Tuesday, April 20, before market openCPG (consumer packaged goods) companies like P&G were early and obvious winners from the pandemic. A surge in supermarket revenue and consumer stockpiling led to unusually high growth.But normalcy is returning — which isn’t necessarily great news for P&G and its industry. Toilet paper sales, for instance,have plunged this yearas many consumers still are working through purchases made last year.Those trends set up a big fiscal third quarter release for P&G on Tuesday morning. PG stock has rallied in recent weeks after fading to an eight-month low in early March. A 23x forward price-to-earnings multiple is well above recent levels. And Q3 is the first of several quarters in which the company will face difficult, pandemic-driven, year-prior comparisons.Particularly with PG up about 12% in six weeks, Q3 results need to be strong ahead of more difficult compares in fiscal Q4 and fiscal Q1. If they’re not, PG stock could stumble after the release — and bring other CPG stocks with it.Earnings Reports to Watch: Netflix (NFLX)Earnings Report Date: Tuesday, April 20, after market closeNetflix too seems like an obvious pandemic winner. Early on, NFLX stock was treated as such, as it rallied quickly off March 2020 lows and touched an all-time high in early July.Since then, however, NFLX has been stuck. One obvious reason why is that investor attention has turned to other streaming plays such asRoku(NASDAQ:ROKU) and direct Netflix competitorsDisney(NYSE:DIS) andViacomCBS(NASDAQ:VIAC,NASDAQ:VIACA).But earnings haven’t necessarily helped, either. NFLX stock did jump after January’s Q4 report despite a bottom-line miss, but the gains receded in a matter of weeks. Subscriber growthslowed in Q3, which the company attributed to the spike in sign-ups amid the pandemic.With normalcy returning, earnings this week can set the 2021 narrative. A blowout quarter in the face of so much new competition establishes Netflix as the king of streaming, with other services simply fighting for second place. Any weakness, particularly in the subscriber count, might suggest that those new platforms are pulling Netflix subscribers away.With the forward earnings multiple down to a more reasonable 43x, NFLX stock is cheap enough to break out if its dominance appears assured. And with incremental margins from additional subscribers driving the expected profit growth, it’s expensive enough to plunge if top-line momentum slows. This looks like a big quarter for NFLX stock — and big enough to move other streaming names as well.AT&T (T)Earnings Report Date: Thursday, April 22, before market openOne of those new Netflix competitors, of course, is AT&T. The telecommunications giant launched its HBO Max streaming service in May. Despiteclearing 60 million worldwide subscribersby the end of last year, HBO Max hasn’t done much for T stock.Of course, nothing has done much for the stock, which actually is down 2% over the past decade. Investors have received a generally healthy dividend, which now yields 7%. But in terms of share price appreciation, AT&T stock has been the definition of ‘dead money’.Something needs to change. It’s hard to see what that will be. HBO Max’s growth has been impressive, but the streaming business is cannibalizing revenue from DIRECTV as well as WarnerMedia’s TNT and TBS cable channels. In wireless, AT&T continues to lose share toVerizon Communications(NYSE:VZ), which reports on Wednesday morning, and a now-largerT-Mobile(NASDAQ:TMUS).Simply put, beyond the dividend yield AT&T hasn’t given investors a good reason to own T stock. It needs to start doing so, and Thursday morning would be a fine time to start. AT&T needs to print sustainable growth either in wireless or in WarnerMedia as a whole. Of course, as the last few years show, that’s easier said than done.Earnings Reports to Watch: Intel (INTC)Earnings Report Date: Thursday, April 22, after market closeEarnings this week look absolutely crucial for Intel. INTC plunged after back-to-back earnings reports last year amidyet another stumblein its move to the 7nm node. News in December thatApple(NASDAQ:AAPL) andMicrosoft(NASDAQ:MSFT) weredeveloping their own chipsended a relief rally and sent the stock back to the lows.Yet earlier this month INTC threatened its highest level since a brief 2000 peak amid the dot-com bubble. A better-than-expected Q4 release in January certainly helped. But the chip shortage has proved a catalyst as well. In this environment, Intel’s owned manufacturing capacity gives it an edge over ‘fabless’ rivalsAdvanced Micro Devices(NASDAQ:AMD) andNvidia(NASDAQ:NVDA).In other words, Intel has gotten a reprieve. It’s an advantage the company absolutely must take advantage of. With INTC still trading at 14x forward earnings, the stock is cheap enough that the rally can continue if Intel doesn’t give investors a reason to sell.That might seem like a low bar to clear — but Intel’s recent history suggests otherwise.","news_type":1},"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373539398,"gmtCreate":1618871082614,"gmtModify":1704716011267,"author":{"id":"3581676194356767","authorId":"3581676194356767","name":"johnson69","avatar":"https://static.tigerbbs.com/427e67743c2dda94609a151f247459a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581676194356767","authorIdStr":"3581676194356767"},"themes":[],"htmlText":"apple is great :)","listText":"apple is great :)","text":"apple is great :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/373539398","repostId":"1164936386","repostType":4,"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373597833,"gmtCreate":1618870842022,"gmtModify":1704716008827,"author":{"id":"3581676194356767","authorId":"3581676194356767","name":"johnson69","avatar":"https://static.tigerbbs.com/427e67743c2dda94609a151f247459a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581676194356767","authorIdStr":"3581676194356767"},"themes":[],"htmlText":"apple is great","listText":"apple is great","text":"apple is great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/373597833","repostId":"1164936386","repostType":4,"repost":{"id":"1164936386","pubTimestamp":1618841871,"share":"https://ttm.financial/m/news/1164936386?lang=&edition=fundamental","pubTime":"2021-04-19 22:17","market":"us","language":"en","title":"Should You Buy Apple Stock Before Next Apple Event?","url":"https://stock-news.laohu8.com/highlight/detail?id=1164936386","media":"TheStreet","summary":"On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Ap","content":"<p>On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.</p>\n<p>A&nbsp;new Apple Event lurks around the corner. Beyond the curiosity for what new products will be unveiled, investors will also pay attention to how Apple stock will behave. Below, the Apple Maven reviews how the previous events aﬀected share price behavior in 2020.</p>\n<p><b>The effect of Apple events on the stock</b></p>\n<ul>\n <li><b>Apple’s “One More Thing” – November 30, 2020</b>:The highlight of the event&nbsp;was Apple’s introduction of the M1-equipped MacBook Air, 13‑inch MacBook Pro and Mac mini. In the following three months, the stock climbed 23%, reaching all-time highs by January 2021.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ef348206ee5454f0af9c8828e7906b91\" tg-width=\"1240\" tg-height=\"361\"><span>Figure 1: Apple stock performance after \"One More Thing\" event.</span></p>\n<ul>\n <li><b>Apple’s “Hi, Speed” – October 13, 2020</b>:The Cupertino company introduced&nbsp;the highly anticipated iPhone 12 and iPhone 12 Pro with 5G connectivity, MagSafe accessories, and the HomePod mini. This could be considered the main event of the year, since the iPhone is Apple’s key revenue driver. However, the stock dropped 4% between the iPhone launch and the “One More Thing” event.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9c24a3a51e2e31f611a844d66b0a0255\" tg-width=\"1240\" tg-height=\"367\"><span>Figure 2: Apple stock performance after \"Hi, Speed\" event.</span></p>\n<ul>\n <li><b>Apple’s “Time Flies” – September 15, 2020</b>:In this action-packed event, the Apple Watch Series 6, Apple Watch SE, the new iPad Air and iPad, Apple Fitness+ and Apple One were introduced. Apple stock climbed 4% in the six weeks between “Time Flies” and “Hi, Speed”.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a232bac33db421d697d4ebb8cabccd96\" tg-width=\"1240\" tg-height=\"368\"><span>Figure 3: Apple stock performance after \"Time Flies\" event.</span></p>\n<ul>\n <li><b>Apple’s WWDC – June 22, 2020</b>: In the2020 version of the Worldwide Developers Conference, updates to iOS, iPadOS, watchOS and macOS Big Sur were announced. Very importantly, Apple’s introduction of the M1 chip also took center stage. The conference was hosted online for the first time, due to the COVID-19 pandemic. In the following 3 months, Apple shares climbed an impressive 50% to its early September peak.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/adfa652d946092e94e4a8ba657e950a0\" tg-width=\"1240\" tg-height=\"370\"><span>Figure 4: Apple stock performance after \"WWDC\" event.</span></p>\n<p><b>What about the next Apple Event?</b></p>\n<p>At least in 2020, Apple stock performed generally well in the days following the company’s events – although it is hard to establish causation with much certainty. Investors who bought shares ahead of the key dates, except for “Hi, Speed”, saw decent gains in a short period.</p>\n<p>But will the upcoming event guide the stock higher this time?</p>\n<p>The Apple Maven doubts&nbsp;that the iPad, the likely star of Tuesday’s announcements, will be a game changer for Apple stock the same way that the iPhone or new products in mixed reality and autonomous vehicles could be. But it is important for Apple to keep the momentum going in the tablet business, taking advantage of trends in work-from-home and tablet-as-a-PC.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should You Buy Apple Stock Before Next Apple Event?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould You Buy Apple Stock Before Next Apple Event?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-19 22:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.\nA new...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/should-you-buy-apple-stock-before-next-apple-event","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164936386","content_text":"On April 20, Apple will host a product launch event, and at least a new iPad Pro is expected. The Apple Maven looked at recent history to see how the stock performed after the past Apple Events.\nA new Apple Event lurks around the corner. Beyond the curiosity for what new products will be unveiled, investors will also pay attention to how Apple stock will behave. Below, the Apple Maven reviews how the previous events aﬀected share price behavior in 2020.\nThe effect of Apple events on the stock\n\nApple’s “One More Thing” – November 30, 2020:The highlight of the event was Apple’s introduction of the M1-equipped MacBook Air, 13‑inch MacBook Pro and Mac mini. In the following three months, the stock climbed 23%, reaching all-time highs by January 2021.\n\nFigure 1: Apple stock performance after \"One More Thing\" event.\n\nApple’s “Hi, Speed” – October 13, 2020:The Cupertino company introduced the highly anticipated iPhone 12 and iPhone 12 Pro with 5G connectivity, MagSafe accessories, and the HomePod mini. This could be considered the main event of the year, since the iPhone is Apple’s key revenue driver. However, the stock dropped 4% between the iPhone launch and the “One More Thing” event.\n\nFigure 2: Apple stock performance after \"Hi, Speed\" event.\n\nApple’s “Time Flies” – September 15, 2020:In this action-packed event, the Apple Watch Series 6, Apple Watch SE, the new iPad Air and iPad, Apple Fitness+ and Apple One were introduced. Apple stock climbed 4% in the six weeks between “Time Flies” and “Hi, Speed”.\n\nFigure 3: Apple stock performance after \"Time Flies\" event.\n\nApple’s WWDC – June 22, 2020: In the2020 version of the Worldwide Developers Conference, updates to iOS, iPadOS, watchOS and macOS Big Sur were announced. Very importantly, Apple’s introduction of the M1 chip also took center stage. The conference was hosted online for the first time, due to the COVID-19 pandemic. In the following 3 months, Apple shares climbed an impressive 50% to its early September peak.\n\nFigure 4: Apple stock performance after \"WWDC\" event.\nWhat about the next Apple Event?\nAt least in 2020, Apple stock performed generally well in the days following the company’s events – although it is hard to establish causation with much certainty. Investors who bought shares ahead of the key dates, except for “Hi, Speed”, saw decent gains in a short period.\nBut will the upcoming event guide the stock higher this time?\nThe Apple Maven doubts that the iPad, the likely star of Tuesday’s announcements, will be a game changer for Apple stock the same way that the iPhone or new products in mixed reality and autonomous vehicles could be. But it is important for Apple to keep the momentum going in the tablet business, taking advantage of trends in work-from-home and tablet-as-a-PC.","news_type":1},"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}